[1] 周玉保,汪慧,周华邦,等. 肝脏局灶性结节性增生46例临床分析. 临床消化病杂志,2009,2（3）:146-149.
[2] 周成香,刘亚斌,罗渝昆. 肝脏局灶性结节性增生的超声影像特征.实用医院临床杂志,2011,8（1）:34-37.
[3] 严茂林,王耀东,田毅峰,等. 肝局灶性结节性增生265例诊治分析. 中华肝胆外科杂志,2011,17（5）:423-424.
[4] 陈伶俐,纪元,许建芳,等. 肝脏局灶结节性增生238例临床病理分析.中华病理学杂志,2011,40（1）:17-22.
[5] 厉学民,张家敏,毛根军,等. 肝脏局灶结节性增生的诊断与治疗.中国中西医结合外科杂志,2012,18:229-231.
[6] Cong WM,Dong H,Tan L,et al. Surgicopathological classification of hepatic space-occupying lesions：a single-center experience with literature review. World J Gastroenterol,2011,17（19）：2372-2378.
[7] Bioulac-Sage P,Rebouissou S,Sa Cunha A,et al. Clinical, morphologic,and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology,2005,128:1211-1218.
[8] Nouso K,Yoshiyuki H,Shinichiro K,et al. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein. J Gastroenterol Hepatol,2011,26（7）：1195-1200.
[9] 范存雷,任国政,魏祥,等. 肝脏局灶性结节性增生的CT诊断价值及外科治疗. 河南医学研究,2009,18（2）：152-155.
[10] 黄刚,汤庆,樊丽红,等. 肝脏局灶性结节增生25例临床分析. 重庆医学,2010,39（10）：1196-1197.
[11] 张立明,王人颢,温泉.肝脏局灶性结节性增生的临床诊治分析. 中国医药科学,2012,2（3）：48-50.
[12] Yao M,Yao DF,Bian YZ,et al. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int,2011,10（3）：289-294.
[13] Kapp N,Curtis KM.Hormonal contraceptive use among women with liver tumors：a systematic review. Contraception,2009,80（4）：387-390.
[14] 赵宏,蔡建强,兰忠民,等. 肝脏局灶结节性增生的诊断和治疗. 中华肝胆外科杂志,2009,15:423-426.
[15] Halankar JA,Kim TK,Jang HJ,et al. Understanding the natural history of focal nodular hyperplasia in the liver with MRI. Indian J Radiol Imaging,2012,22:116-120. |
